2PENDLAND S L,NEUHAUSER M M,GAREY K W,et al.Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates:impact of bacterial strain and antibiotic concentration[J].Diagn Microbiol Infect Dis,2002,44(1):59.
4FUKUDA H,HOKI S,HIRAMATSU K.Antibacterial activity of gatifloxacin(AM-1155,CG-5501,BMS-206584),a newly developed fluoroquinlolne,against sequentially acquird quinlolneresistant mutants and the norA transformant of Staphylococcus aureus[J].Antimicrob Agent Chemother,1998,42(8):1 917.
二级参考文献8
1Masaki H, Tokutaro Y, Hideyuki F, et al. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone [J]. Antimicrob Agents Chemother,1992;36:2108
2Barruga G, Alarcon N, Rojas L C. In vitro activity of gatifloxacin and 18 other antibiotics against respiratory tract pathogens. Program and abstracts of the 39th interscience conference on antimicrobial agents and chemotherapy [C].San Francisco, September 26-29,1999
3Gary E, Stein T. The methoxyfluroquinolones: Gatifloxacn and moxifloxacin [J]. Infect Med ,2000; 17(8) :564
4Biedenbach DJ, Crco M A J, Jones R N, et al. Antirnicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinoloneresistant strains [J]. Diagn Microbiol Infect Dis, 1998;32:307
5Inshida K, Kaku M, lrifune K, et al. In vitro and in vivo activity of a new quinolone AM-1155 against Mycoplasma pneunoniae [J]. J Antimicrob Chemother , 1994;34: 875
6Dennis M, Grasela D. Clinical pharmacology of gatifloxacin,a new fluoroquinolone [J]. Clin Infect Dis, 2000; 31 (Supp 12):s51
7Nakashima M, Uematsu T, Kosuge K, et al. Single-and multiple-dose pharrnacokinetics of AM-1155, a new 6-fluoro8-methoxy quinolone, in humans [J]. Antimicrob Agents Chemother, 1995; 39:2635
8Broccn J, Skuba K, Grascla D. Safety and tolerability of gatifloxacin, an advanced generation, 8-methoxy fluoroquinolone[J].J Res Dis, 1999; 20 (Suppl): S70
